Ubiquitin-conjugating enzyme

Ubiquitin-conjugating enzymes, also known as E2 enzymes and more rarely as ubiquitin-carrier enzymes, perform the second step in the ubiquitination reaction that targets a protein for degradation via the proteasome. The ubiquitination process covalently attaches ubiquitin, a short protein of 76 amino acids, to a lysine residue on the target protein. Once a protein has been tagged with one ubiquitin molecule, additional rounds of ubiquitination form a polyubiquitin chain that is recognized by the proteasome's 19S regulatory particle, triggering the ATP-dependent unfolding of the target protein that allows passage into the proteasome's 20S core particle, where proteases degrade the target into short peptide fragments for recycling by the cell. A ubiquitin-activating enzyme, or E1, first activates the ubiquitin by covalently attaching the molecule to its active site cysteine residue. The activated ubiquitin is then transferred to an E2 cysteine. Once conjugated to ubiquitin, the E2 molecule binds one of several ubiquitin ligases or E3s via a structurally conserved binding region. The E3 molecule is responsible for binding the target protein substrate and transferring the ubiquitin from the E2 cysteine to a lysine residue on the target protein. File:Ubiquitylation.png|Schematic diagram of the ubiquitylation system. A particular cell usually contains only a few types of E1 molecule, a greater diversity of E2s, and a very large variety of E3s. In humans, there are about 30 E2s which can bind with one of the 600+ E3s. The E3 molecules responsible for substrate identification and binding are thus the mechanisms of substrate specificity in proteasomal degradation. Each type of E2 can associate with many E3s. E2s can also be used to study protein folding mechanisms. Since the ubiquitylation system is shared across all organisms, studies can use modified E2 proteins in order to understand the overall system for how all organisms process proteins. There are also some proteins which can act as both and E2 and an E3 containing domains which cover both E2 and E3 functionality.

À propos de ce résultat

Cette page est générée automatiquement et peut contenir des informations qui ne sont pas correctes, complètes, à jour ou pertinentes par rapport à votre recherche. Il en va de même pour toutes les autres pages de ce site. Veillez à vérifier les informations auprès des sources officielles de l'EPFL.

Concepts associés (5)

Cours associés (1)

Séances de cours associées (16)

BIO-212: Biological chemistry I

Biochemistry is a key discipline for the Life Sciences. Biological Chemistry I and II are two tightly interconnected courses that aim to describe and understand in molecular terms the processes that m

Modifications post-traductionnelles des protéines

Fournit un aperçu des modifications des protéines post-traductionnelles, y compris la phosphorylation, l'ubiquitination et l'acylation.

Modifications protéiques: ubiquitination et acylation

Explore les modifications des protéines par l'ubiquitination, l'acylation et l'importance de l'acylation Ras.

Conception de dégradateurs de protéines ciblés

Explore la conception et la validation de dégradeurs protéiques ciblés, y compris les PROTAC et les composés moléculaires de colle, en soulignant l'importance des analyses et des validations appropriées dans la recherche de la DPT.

Endoplasmic-reticulum-associated protein degradation (ERAD) designates a cellular pathway which targets misfolded proteins of the endoplasmic reticulum for ubiquitination and subsequent degradation by a protein-degrading complex, called the proteasome. The process of ERAD can be divided into three steps: The recognition of misfolded or mutated proteins depends on the detection of substructures within proteins such as exposed hydrophobic regions, unpaired cysteine residues and immature glycans.

L'APC/C ou complexe de promotion de l'anaphase (en : anaphase promoting complex) est un complexe protéique et une ubiquitine ligase E3. L'APC/C a une durée de vie courte, il active l'anaphase une fois que le dernier signal inhibiteur permettant le contrôle de la métaphase est levé. Ce signal est, dans un ordre chronologique, la mise sous tension du centromère par un accrochage amphitélique des microtubules (MT) kinétochoriens dans les kinétochores de chaque chromosome.